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Mice with combined gene knock-outs reveal essential and
partially redundant functions of amyloid precursor protein family
members
Abstract
The amyloid precursor protein (APP) involved in Alzheimer's disease is a member of a larger gene
family including amyloid precursor-like proteins APLP1 and APLP2. We generated and examined the
phenotypes of mice lacking individual or all possible combinations of APP family members to assess
potential functional redundancies within the gene family. Mice deficient for the nervous system-specific
APLP1 protein showed a postnatal growth deficit as the only obvious abnormality. In contrast to this
minor phenotype, APLP2(-/-)/APLP1(-/-) and APLP2(-/-)/APP(-/-) mice proved lethal early postnatally.
Surprisingly, APLP1(-/-)/APP(-/-) mice were viable, apparently normal, and showed no compensatory
upregulation of APLP2 expression. These data indicate redundancy between APLP2 and both other
family members and corroborate a key physiological role for APLP2. This view gains further support by
the observation that APLP1(-/-)/APP(-/-)/APLP2(+/-) mice display postnatal lethality. In addition, they
provide genetic evidence for at least some distinct physiological roles of APP and APLP2 by
demonstrating that combinations of single knock-outs with the APLP1 mutation resulted in double
mutants of clearly different phenotypes, being either lethal, or viable. None of the lethal double mutants
displayed, however, obvious histopathological abnormalities in the brain or any other organ examined.
Moreover, cortical neurons from single or combined mutant mice showed unaltered survival rates under
basal culture conditions and unaltered susceptibility to glutamate excitotoxicity in vitro.
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The amyloid precursor protein (APP) involved in Alzheimer’s dis-
ease is a member of a larger gene family including amyloid
precursor-like proteins APLP1 and APLP2. We generated and
examined the phenotypes of mice lacking individual or all pos-
sible combinations of APP family members to assess potential
functional redundancies within the gene family. Mice deficient for
the nervous system-specific APLP1 protein showed a postnatal
growth deficit as the only obvious abnormality. In contrast to this
minor phenotype, APLP22 /2/APLP12 /2 and APLP22 /2/
APP2 /2 mice proved lethal early postnatally. Surprisingly,
APLP12 /2/APP2 /2 mice were viable, apparently normal, and
showed no compensatory upregulation of APLP2 expression.
These data indicate redundancy between APLP2 and both other
family members and corroborate a key physiological role for
APLP2. This view gains further support by the observation that
APLP12 /2/APP2 /2/APLP21/2 mice display postnatal lethality.
In addition, they provide genetic evidence for at least some
distinct physiological roles of APP and APLP2 by demonstrating
that combinations of single knock-outs with the APLP1 mutation
resulted in double mutants of clearly different phenotypes, being
either lethal, or viable. None of the lethal double mutants dis-
played, however, obvious histopathological abnormalities in the
brain or any other organ examined. Moreover, cortical neurons
from single or combined mutant mice showed unaltered survival
rates under basal culture conditions and unaltered susceptibility
to glutamate excitotoxicity in vitro.
Key words: amyloid precursor protein; amyloid precursor-like
protein; knock-out mice; functional redundancy; excitotoxicity;
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Neurofibrillary tangles and senile neuritic plaques are the major
pathological features of Alzheimer’s disease. The predominant
constituent of neuritic plaques is the b-amyloid peptide (bA4),
proteolytically derived from the larger b-amyloid precursor protein
(APP). APP is a member of a larger gene family including the two
amyloid precursor-like proteins APLP1 and APLP2 from mam-
mals (Wasco et al., 1992, 1993; Sprecher et al., 1993; Sandbrink et
al., 1994; Slunt et al., 1994). Both APLPs are highly homologous to
APP and are proteolytically processed in a similar way, leading to
the secretion of the large ectodomains (sAPP and sAPLP) (Slunt et
al., 1994; Paliga et al., 1997). Using in situ hybridization and
RT-PCR analysis, we and others have demonstrated that APP and
APLP2 are expressed ubiquitously in largely overlapping patterns
during embryonic development and in adult tissue (Slunt et al.,
1994; Lorent et al., 1995). In contrast, APLP1 is found primarily in
the nervous system (Lorent et al., 1995; Thinakaran et al., 1995c).
APP is axonally transported, has been localized to synapses, and
undergoes retrograde and transcytotic transport in neurons (Si-
mons et al., 1995; Yamazaki et al., 1995). APLP2 has been detected
in postsynaptic compartments throughout the cortex and in axonal
termini of olfactory sensory neurons (Thinakaran et al., 1995a,b).
In summary, APP/APLP proteins are highly related, are similarly
processed, share overlapping domains of expression, and may
therefore also be functionally conserved.
Multiple functions have been proposed for APP, mainly based
on in vitro experiments (for review, see Mattson, 1997). To address
the physiological functions of APP directly, we and others have
generated mice carrying a hypomorphic mutation of APP (APPD;
Mu¨ller et al., 1994) and APP-deficient null mutants (Zheng et al.,
1995; Li et al., 1996). The phenotypes of these mutants suggested
that APP may play a role in neurite outgrowth and the formation
of forebrain commissures, postnatal somatic growth and neurobe-
havioral development, locomotor activity and grip strength, copper
homeostasis, and the susceptibility to epileptic seizures and exci-
totoxic agents (Zheng et al., 1995; Li et al., 1996; Perez et al., 1997;
Steinbach et al., 1998; Tremml et al., 1998; Magara et al., 1999;
White et al., 1999a,b). APLP22 /2 mice showed no apparent ab-
normalities, but double mutants obtained by crossing APP2 /2 mice
(obtained from H. Zheng, H. Chen, M. Trumbauer, and L. H. T.
van der Ploeg) to APLP22 /2 mice were perinatally lethal, suggest-
ing functional redundancy (von Koch et al., 1997).
This study investigates the phenotype of APLP12 /2 mice and
addresses the question of functional complementation within the
gene family by analyzing all possible combinations of double mu-
tants. We show that APP family members serve essential, at least
partially redundant functions by demonstrating early postnatal
lethality for both APLP22 /2/APLP12 /2and APLP22 /2/APP2 /
2double mutants. In addition, we provide genetic evidence for
distinct physiological roles of APP and APLP2, by showing that
crosses of the respective single knock-outs with APLP1 knock-out
mice result in double mutants of clearly different phenotypes, being
either lethal (APLP22 /2/APLP12 /2), or viable (APP2 /2/
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APLP12 /2). Moreover, we investigated the presumed neuropro-
tective role of endogenous APP family members.
MATERIALS AND METHODS
Generation of APLP12 /2 embryonic stem cells
Using as a probe a 0.4 kb PstI fragment derived from the 59-end of the
APLP1 cDNA (Wasco et al., 1992) two overlapping l clones encompassing
;19 kb of genomic sequence were isolated from an isogenic lGem11
genomic library constructed from AB-1 [129/Sv(ev)] embryonic stem (ES)
cells. As judged from hybridization experiments with various oligonucle-
otides derived from different regions of the APLP1 cDNA and partial
sequencing the genomic clones contained the whole coding region includ-
ing the putative first exon (cDNA positions 9–229) harboring the ATG
start codon. Apart from exon1 and exon2 the precise location of the other
exons was not mapped. The targeting vector pAPLP1targ was constructed
by inserting a blunted 0.9 kb SacI /XhoI fragment lying 2.5 kb upstream of
putative exon1 into the NotI site of pTKNEOUMSPSA, a slightly modified
vector (containing additional restriction sites) derived from the previously
described plasmid pTKNEOUMS (Ruffner et al., 1993). Subsequently a
blunted 4.7 kb XhoI /KpnI fragment was inserted as the “long arm” of
homology into the unique ClaI site of the vector. In this construct the neo R
gene under the control of the phosphoglycerate kinase (PGK) promoter
was in antisense orientation to the transcriptional direction of the APLP1
gene and was followed by the 360 bp UMS sequence reported to mediate
transcription termination. A herpes simplex virus thymidine kinase (HSV-
TK) cassette was added at the 39 end to allow for counterselection.
Homologous recombination leads to a ;8 kb genomic deletion containing
;2.5 kb of the promoter. To determine how much of the coding region
would be deleted by gene targeting, hybridization experiments were per-
formed showing that the deleted region contained coding sequences up to
approximately position 1000 of the 2.36 kb cDNA, as judged by hybridiza-
tion to oligo UM14 (cDNA position 1014–1034).
The targeting vector was subsequently linearized with SacII at the 59
border of the APLP1 genomic region, electroporated into GS1 ES cells
[established by Gerlinde Stark from 129 Sv(ev) mice] grown on irradiated
mouse embryonic fibroblasts in DMEM supplemented with 20% fetal calf
serum (D20). Colonies resistant to neomycin and 1-(2-deoxy-2-flouro-b-
D-arabinosifuranosyl)-5-ioduracil (FIAU) were selected in D20 containing
400 mg of G-418 and 0.2 mM FIAU and screened as described (Mu¨ller et al.,
1994) by PCR using a primer derived from the 39 end of the neo-cassette
(P3: 59-ATTCGCAGCGCATCGCCTTCTATCGCC-39) and a primer
corresponding to a genomic sequence 59 from the targeting vector (UM20:
59-GGATTTCAGCCCTGGTTCCCATTCTAACCC-39). The frequency
of homologous recombination was ;1 in 500 G-418/FIAU-resistant
colonies.
Generation of APLP12 /2 mice
ES cells heterozygous for the mutant APLP1 gene were injected into
3.5-d-old C57BL/6 blastocysts that were transferred into the uteri of
pseudopregnant NMRI foster mothers. One of four clones investigated
(clone GS-34.4) gave rise to a chimeric male that was mated to C57BL/6
females [and 129 Sv(ev) females for pure genetic background, respectively]
and transmitted the mutant allele in the germline as revealed by PCR and
Southern blot analysis. Heterozygous offspring were intercrossed and gen-
erated 20% homozygous APLP1 2/2 animals (65 animals analyzed).
Animals and PCR genotyping
APLP1 knock-out mice [of either pure 129Sv(ev) or mixed 129
Sv(ev)xC57BL/6 genetic background] were initially screened with primers
UM20/P3 as described for ES cells. Later, a simpler 3-primer PCR was
used amplifying for the wild-type (wt) allele a 600 bp fragment with
primers UM30 (59-GCTTTCTGCCTTCATGCCTATCTCTAG-39) and
UM31 (59-ACTTTGGCTGAACTGAGTGTACACC-39) derived from
the short arm of the targeting vector or from the region replaced by neo,
respectively. For the mutant allele a 450 bp product was obtained with
primers UM30 and P4-neo (59-ATGCGGTGGGCTCTATGGCTTCTGA-
39) derived from the PGK-Neo-cassette.
APLP2 knock-out mice [129Sv(ev)xC57BL/6 genetic background] were
generated and genotyped as described (von Koch et al., 1997).
APP knock-out animals (129OLAxC57BL/6 genetic background) har-
bor a 200 kb genomic deletion within the APP locus encompassing exon
2–17 of the APP gene and were generated as described (Li et al., 1996;
Magara et al., 1999). For genotyping, a 3-primer PCR was set up ampli-
fying for the wt allele a 650 bp fragment with primers UM44 (59-
GAGACGAGGACGCTCAGTCCTAGGG-3)andUM42(59-ATCACCT-
GGTTCTAATCAGAGGCCC-39) flanking exon 17 and for the mutant
allele a 430 bp fragment with primers UM42 located in intron 17 and
P3-hygro (59-CGAGATCAGCAGCCTCTGTTCCACA-39) derived from
the PGK-Hygro-cassette, respectively. PCR was done on DNA obtained
from tail biopsies as previously described (Mu¨ller et al., 1994).
Animals were housed in a special pathogen-free unit kept under optimal
hygiene conditions. Timed matings were set up in the late afternoon
followed by plug check on the next morning. The time point of a detected
plug was considered as embryonic day 0.5 (E0.5).
Generation of combined mutants
Double mutants were generated by three consecutive crosses. Single mu-
tants of APP family members (e.g., APLP1 2 /2 3 APLP2 2 /2) were
intercrossed, and animals heterozygous for both loci were backcrossed to
single mutants (e.g., APLP1 1/2APLP2 1/2 3 APLP2 2 /2) to obtain 25%
offspring homozygous knock-out for one gene and heterozygous for the
other (e.g., APLP11/2APLP22/2). These animals were further inter-
crossed (APLP11/2APLP22/2 3 APLP11/2APLP22/2) to obtain double
knock-outs in the next generation (e.g., 25% APLP1 2 /2APLP2 2 /2, 25%
APLP1 1/1APLP2 2 /2, and 50% APLP1 1/2APLP2 2 /2). Accordingly, to
obtain APP/APLP2 and APP/APLP mutants the respective analogous
crosses were set up, and double knock-outs were generated in the third round
of crossing from the following matings: (APP 1/2APLP2 2 /2 3 APP 1/
2APLP2 2 /2) and (APP 1/2APLP1 2 /2 3 APP 1/2APLP1 2 /2). APP 2 /2/
APLP1 2 /2/APLP2 1/2 mice were generated by crossing APP 2 /2/
APLP1 2 /2 mice with APP 2 /2/APLP1 1/2/APLP2 1/2 mice.
Southern and Northern blot analysis of APLP2/2 mice
Southern blots were prepared from APLP1 ES cell or tail DNA digested
with HindIII or EcoRI, cutting outside of the targeting vector and sepa-
rated by conventional or pulsed-field gel electrophoresis [1% agarose in 45
mM Tris-borate, 1 mM EDTA run for 15 hr at 6 V/cm, 120° angle, switch
time being from 0.5–2.0 sec in a Bio-Rad (Hercules, CA) DRIII apparatus].
Hybridization was performed with a random primer 32P-labeled (PrimeIt;
Stratagene, La Jolla, CA) genomic 0.5 kb PstI fragment (Fig. 1, probe B)
and a 0.6 kb PstI /XbaI-fragment of pGKneo.
For Northern blots, total RNA (prepared as described in Mu¨ller et al.,
1994) or polyA-RNA [prepared using Oligotex columns from Qiagen
(Hilden, Germany)] was separated on 1% denaturing agarose gels and
transferred by capillarity to HybondN1 (Amersham, Arlington Heights,
IL) membrane. A 32P-labeled RNA probe containing 570 nt from the 39
end of the APLP1 cDNA was prepared by in vitro transcription with T7
polymerase using EcoRV linearized pBSKAPLP1 as the template (Wasco
et al., 1992). To check for APP expression, a genomic 0.7 kb EcoRI/ScaI
fragment subcloned into pBluescript and comprising exon 2 was used as
the template for in vitro transcription.
Northern blots were hybridized with riboprobes overnight at 65°C in
50% formamide solution containing 53 SSC, 53 Denhardt’s solution, 1%
SDS, 0.1% Na Pyrrophosphate, 5 mM EDTA, and 300 mg/ml yeast tRNA.
Washing of blots was at 65°C for 20 min in 0.23 SSC and 0.5% SDS. After
autoradiography blots were stripped by boiling for 10 min in 20 mM Tris-HCl,
pH 8.0, 2 mM EDTA, and 0.5% SDS and rehybridized with a random primer
32P-labeled 490 bp XhoII fragment of the rat glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) cDNA.
Western blot analysis
Mouse organs were homogenized in ;10 vol of homogenization buffer
(0.5% SDS and 50 mM Tris-HCl, pH 6.8, 5 mM EDTA, 50 mg/ml pepstatin,
and 0.25 mM PMSF) per gram of tissue, using a Ultra-Turrax T25 (IKA
Labortechnik) blender. The homogenates were boiled for 10 min, centri-
fuged for 10 min at 12,000 3 g, and the supernatants were recovered.
Protein concentrations were determined by the BCA method (Pierce,
Rockford, IL). Proteins were separated on Standard (La¨mmli) 12% SDS-
polyacrylamide gels using the protean II system (Bio-Rad) and electro-
transferred to nitrocellulose membrane in low glycine buffer at 10 mA for
17 hr with wet transfer equipment (Bio-Rad). Filters were blocked for 1 hr
in TBST (20 mM Tris-HCl, pH 7.6, 137 mM NaCl, and 0.1% Tween 20)
containing 5% nonfat dry milk. The blot was incubated overnight with the
primary antibody (e.g., rabbit antiserum CT-11 at a dilution of 1:2000 in
TBST and 1% nonfat dry milk) followed by an 1 hr incubation with
HRP-coupled secondary antibody [swine anti-rabbit IgG from Dako
(Carpinteria, CA) at a dilution of 1:2500 in TBST and 1% nonfat dry milk]
and developed by the ECL reaction (Pierce).
Antibodies used for Western blotting: CT-11 is a rabbit polyclonal
serum raised against a synthetic peptide comprising the 11 C-terminal
amino acids of murine APLP1 and is not cross-reacting with either APP or
APLP2 (Thinakaran et al., 1995c). APLP2 was specifically detected with
rabbit serum D2II (dilution 1:2000) as described (Thinakaran and Sisodia,
1994), and APP-specific staining was obtained with antibody 22C11 (dilu-
tion 1:1000; Chemicon). anti-Actin staining was performed with antibody
C4 (dilution 1:10,000; ICN Biomedicals, Cleveland, OH).
Anatomical and histological analysis
Immunohistochemistry. Immunohistochemistry was done as described pre-
viously (Steinbach et al., 1998). Formaldehyde-fixed, paraffin-embedded,
rehydrated, 2-mm-thick sections were incubated with monoclonal mouse
and polyclonal rabbit antibodies (MAP II; 1:400, Boehringer, Mannheim,
Germany), anti-synaptophysin (1:50, Dako), glial fibrillary acid protein
(GFAP; 1:50, Dako), and b-III tubulin (1:2000, Promega) diluted in PBS
for 2 hr at room temperature. This was followed by incubation with the
secondary antibody (rabbit-anti mouse IgG, Dako) diluted 1:50 in PBS
for 45 min at room temperature. Bound secondary antibody was detected
by using the alkaline phosphatase-anti-alkaline phosphatase complex
(APAAP; mouse monoclonal, Dako) diluted 1:40 in PBS and incubated for
45 min at room temperature. The alkaline phosphatase activity was visu-
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alized by using Astranenfuchsin (Aldrich, Milwaukee, WI). The sections
were counterstained with hemalaun. The immunohistochemical methods
used have previously been validated by us as a sensitive assay to detect
lesions induced by systemic injection of sublethal, low doses of kainate
(Steinbach et al., 1998).
In situ end-labeling assay. Terminal deoxynucleotidyl transferase-
mediated biotinylated UTP nick end labeling (TUNEL) assays were per-
formed on formalin-fixed sections: staining was performed incubating
sections under coverslips with 50 ml of labeling mix [25 U/ml terminal
deoxynucleotidyl transferase (TdT) (Boehringer), Dig-DNA labeling mix
103 concentration (Boehringer), and 2 mM CaCl2 in reaction buffer for
terminal transferase (Boehringer) containing 0.2 M potassium cacodylate
and 25 mM Tris-HCl, pH 7.5] for 60 min at 37°C. After rinsing in
Tris-buffered saline (TBS), sections were blocked with 10% fetal calf
serum (FCS) (Seromed). Sections were then treated for 60 min with
alkaline phosphatase-labeled anti-dioxigenin antibody Fab-fragment
(Boehringer) at a dilution of 1:250 in 10% FCS. After washing in TBS, the
color reaction was visualized by incubating the sections in reaction buffer
(in mM: Tris 100, NaCl 100, and MgCl2 50, pH 9.5) containing 100 mg/ml
4-nitroblue tetrazolium salt and 50 mg/ml 5-bromo-4-chloro-3-indolyl
phosphate (Boehringer) for 5–15 min. The reaction was stopped with TBS,
and sections were counterstained with nuclear fast red (Merck).
Electron microscopy
Brains from newborn mice obtained from wt matings or by intercrosses of
ALPL1 1/2APLP2 2 /2 mice, or APP 1/2APLP2 2 /2 mice, respectively,
were dissected and fixed by immersion in 2% glutaraldehyde in 0.1 M
cacodylate buffer, pH 7.4, containing 2% polyvinyl-pyrrolidone (PVP) for
2 hr. After several rinses in cacodylate buffer with 2% PVP, the brainstems
were post-fixed in 1% OsO4 in cacodylate buffer followed by dehydration in
ethanol and embedding in Epon 812 substitute (Fluka, Neu-Ulm, Germa-
ny). Ultrathin 75 nm sections were cut with an ultramicrotome (Reichert
Ultracut E). Sections were stained with uranyl acetate/ lead citrate and
examined under the electron microscope (Zeiss EM 10C). Images were
recorded with a BioScan Camera (Gatan).
Primary cultures from mouse cortex
Cultures of cortical neurons were prepared with some minor modifications
in analogy to the procedure described by Banker and Goslin (1998) for
hippocampal neurons. Embryos for cortical cultures were obtained from
intercrosses of APLP1 1/2APLP2 2 /2 mice or APP 1/2APLP2 2 /2 mice,
respectively. Genotyping was done by PCR on tail tissue. Wild-type
control mice were obtained from 129 Sv(ev) 3 C57B6 matings and pro-
cessed in parallel. Cortices from single E14.5 mouse embryos were col-
lected in Ca 21- and Mg 21-free HBSS/10 mM HEPES, pH 7.2 (Life
Technologies, Gaithersburg, MD). After addition of trypsin (final concen-
tration 0.05%) neuronal tissue was incubated for 8 min at 37°C. Trypsin
was removed, the suspension was washed with 15 ml of HBSS/HEPES, and
cortices were triturated with 5 ml glass pipettes in plating medium (serum-
free Neurobasal medium supplemented with B27, 0.5 mM glutamine, and
50 U of penicillin–streptomycin; Life Technologies). Cells were seeded in
500 ml of plating medium in 24-well plastic dishes (coated overnight with
10 mg/ml poly-L-lysine hydrobromide in 0.1 M borate buffer, pH 8.5) at a
density of 130,000 cells/well (;73,000 cells/cm 2) and maintained at 37°C in
5% CO2. Neuronal cultures were treated with cytosine-b-D-arabino-
furanoside (Ara-C; final concentration 3 mM, Sigma) dissolved in 250 ml of
plating medium on day 3 in vitro (DIV 3) to prevent glial proliferation.
Neuronal purity was .95% as determined by immunohistochemical
staining against GFAP, performed on DIV 10. Cultures were kept
without further medium change until DIV 15 when survival experiments
were done.
Survival assays and glutamate treatment
To assess spontaneous survival rates, neurons from individual embryos
were cultured on gridded cellocate coverslips (Eppendorf, Hamburg). Live
neurons, as judged by their morphological integrity (with an extended
neurite network, smooth membrane appearance, and noncondensed soma)
were counted within the same area (six nonoverlapping gridded fields, each
covering a total area of 350 3 350 mm, containing ;40–60 neurons per
field, on average 240–360 neurons per sample) once on DIV 1 and again
on DIV 7. Neuron counts were performed for two or three independent
embryos for each genotype. Values represent averages 6 SEM. The rate of
spontaneous survival on DIV 7 was calculated relative to neuron counts
obtained on DIV 1.
Cell survival after glutamate treatment was monitored by 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium-bromide (MTT) assays: yel-
low MTT (Sigma) dissolved in PBS was added to the neuronal cultures to a
final concentration of 0.5 mg/ml and incubated for 1 hr at 37°C. A violet
formazan product is produced by viable cells because of the metabolic
activity of mitochondrial enzymes. The formazan product is dissolved in
250 ml of DMSO and detected by its optical density (OD)D540–690. The
ODD540–690 is taken as a measure of the number of living cells ($95%
neurons) in the culture (Mosmann, 1983).
To investigate cell survival in response to glutamate, neurons were
prepared from individual embryos (8–12 processed in parallel), and cell
suspensions of two cultures were counted before seeding. To correct for
Figure 1. Disruption of the APLP1 gene by gene targeting in ES cells. Our targeting strategy was aimed at abolishing transcription and translation by
generating an ;8 kb genomic deletion comprising 2.5 kb of the putative promoter, the first exon containing the ATG translational start codon and genomic
sequences containing ;50% of the APLP1 coding region. Top, Genomic segment containing the APLP1 locus. Apart from the first and second exon the
precise location of the other exons (Exn) was not mapped. The stippled box represents an arbitrary positioned exon corresponding to coding sequences
around cDNA position 1000. Parentheses indicate a restriction site derived from one of two overlapping l phages. Middle, Targeting vector pAPLP1-targ.
Horizontal arrows indicate the direction of transcription. The hatched box represents a HSV-TK gene. Bottom, The disrupted allele after homologous
recombination. E, EcoRI; H, HindIII; K, KpnI; P, PstI; S, SacI; X, XhoI; neo-probe, 0.6 kb PstI /XbaI fragment of pGKneo; probe B, genomic 0.5 kb PstI
fragment. Brackets represent restriction sites that were destroyed during cloning.
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small differences in initial plating densities between individual cultures,
cell survival was always expressed as relative values of glutamate-treated
cultures normalized to values obtained from untreated cultures derived
from the same embryo. For dose–response experiments different concen-
trations of glutamate (10, 25, 50, 100 mM) dissolved in plating medium were
added to cortical neurons for 24 hr followed by MTT assays. Average
values from triplicate cultures were calculated relative to values from
nontreated cultures for which the mean was set as 100% survival. For each
experiment two or three independent embryos were used, and the exper-
iment was replicated at least three times. In addition, cortical neurons were
treated with 50 mM glutamate for 1 or 3 hr. For each time point, a triplicate
of 24-well cultures were processed in parallel, and mean values were
determined. In addition, triplicate sets of nontreated cultures were ana-
lyzed for each time point. The mean MTT value obtained from these
nontreated cultures (after 0, 1, and 3 hr of incubation) was set as 100% cell
survival for each embryo. Percentage of survival was calculated relative to
these mean values.
RESULTS
Generation and characterization of APLP1
knock-out mice
Inactivation of the murine APLP1 gene was achieved by gene
targeting with a strategy depicted in Figure 1. By homologous
recombination in ES cells we generated an ;8 kb genomic deletion
comprising 2.5 kb of the putative promoter, the first exon contain-
ing the ATG translational start codon and genomic sequences
containing ;50% of the APLP1 coding region. Deletion of the
transcription and translation start sites should completely abolish
APLP1 expression. Mutant ES cells were injected into blastocysts
and gave rise to one chimera that transmitted the mutant allele in
the germ line. Correct homologous recombination was confirmed
by Southern blot analysis of tail DNA that showed the expected
pattern for an interrupted APLP1 locus (Fig. 2A,B). Heterozygous
animals were intercrossed and yielded homozygous APLP1 knock-
out animals at a normal Mendelian frequency. To determine
whether the APLP1 gene was also functionally inactive, Northern
and Southern blot analysis was performed on brain tissue. An
antisense RNA probe (cDNA position 1788–2360) lying down-
stream of the targeted deletion revealed a band of ;2.6 kb on brain
of wt animals, whereas no transcript was detected in APLP12 /2
mutants (Fig. 2D). Western blot analysis with the antibody CT-11,
which is directed against the 11 C-terminal amino acids of APLP1
and discriminates against the related APP and APLP2 proteins,
gave rise to a set of APLP-1-specific bands of 85–100 kDa for wt
brain, but not for mutants, indicating that the gene had been
completely inactivated. Expression of the other family members
APP and APLP2 was unaltered, as judged from Northern (data not
shown) and Western blot analysis (Fig. 3A, lane 1, lane 2 ).
APLP12 /2-animals were viable, fertile, and showed, apart from
a significant body weight deficit of ;10% (mutant males, 25.37 6
0.70 gm; wt males, 27.72 6 0.76 gm; mutant females, 20.01 6 0.47
gm; wt females, 22.12 6 0.55 gm; average age, 9 weeks; n 5 59; p ,
0.001 by two-way ANOVA), emerging in the second week postna-
tally (data not shown), no overt abnormalities until at least 18
months of age. In contrast to APP-deficient mice that exhibit
reduced locomotor activity and reduced forelimb grip strength
(Mu¨ller et al., 1994; Zheng et al., 1995; Tremml et al., 1997),
APLP12 /2 mice showed, compared to wt controls, normal loco-
motor activity, and in adult animals grip strength was unchanged
(data not shown). A subtle retardation of neurobehavioral devel-
opment [as assessed by tests of the Fox (1965) battery] was ob-
served early postnatally (Tremml et al., 1997; data not shown).
Histopathological analysis of brain sections (see Materials and
Methods) showed no morphological alterations; in particular no
agenesis of the corpus callosum was observed [even on a pure
129Sv(ev) genetic background], as opposed to APP-deficient mice
exhibiting commissure defects and a high incidence of callosal
agenesis on a 129-specific background (Magara et al., 1999). Spatial
learning was analyzed by the Morris water maze test, which re-
vealed similar cognitive abilities of APLP12 /2 animals as wt
controls (as assessed by their normal performance in reversal
learning). Surprisingly, however, APLP1-deficient mice showed
improved acquisition learning, which could be attributed to altered
noncognitive components of the behavior, in particular reduced
thigmotaxis (Tremml et al., 1997; P. Tremml, U. Mu¨ller, H.-P.
Lipp, and D. Wolfer, manuscript in preparation). In summary,
ablation of the neuron-specific APLP1 gene results in a rather
minor phenotype that is clearly distinct from that of APP-deficient
mice, suggesting at least some different functions of both proteins.
Generation of mutants with combined gene deficiencies
To address the question of whether the minor phenotype of single
mutants is caused by functional compensation by other APP family
members, we set out to generate all three possible combinations of
double mutants (APP2 /2/APLP22 /2, APLP12 /2/APLP22 /2,
Figure 2. Molecular validation of the APLP1 knock-out. Functional inac-
tivation of the APLP1 gene was confirmed by a combination of Southern
(A, B), Western ( C), and Northern ( D) blot analysis. Genomic tail DNA
from F1 offspring of the germline chimera was digested with HindIII and
hybridized with genomic probe B, as depicted in Figure 1. Note that wt
animals show a single band of 18 kb, whereas in heterozygous APLP1
mutants an additional band of the expected size of 14 kb was detected ( A).
Intercrossing of these heterozygous animals lead to homozygous mutants
(B), as judged by analysis of DNA from mouse embryonic fibroblasts
(MEF ). The respective genotype is depicted above the blots. Western blots
(C) of wt and APLP1 2 /2 mice were prepared as described in Materials and
Methods. Forty micrograms of brain extracts from two APLP1 2 /2 mice
(lanes 1, 2), a wt APLP1 1/1 littermate (lane 3), and a 129 Sv(ev) wt mouse
(lane 4 ) were separated on a 12% standard La¨mmli gel. Incubation with
APLP1-specific antiserum CT11 followed by anti-rabbit horseradish
peroxidase-linked secondary antibody showed a set of APLP-1-specific
bands of 85–100 kDa for wt brain homogenates. In contrast, brain homog-
enates from APLP1 2 /2 animals showed neither APLP1-specific bands of
wt size nor any shorter polypeptides. The blot was developed with chemi-
luminescence reagents (ECL; Amersham). Marker proteins of the indicated
sizes were from Bio-Rad (broad range rainbow markers). Total RNA was
isolated from brain of either mutant or wt animals, and poly(A1) RNA was
prepared from 120 mg of total RNA. Northern blot analysis (D) with an
antisense RNA probe (cDNA position 1788–2360) lying downstream of the
targeted deletion revealed a band of 2.4 kb on brain of wt animals, whereas
no transcript was detected in organs from APLP1 2 /2 mutant animals.
After autoradiography, filters were stripped and rehybridized with a
GAPDH probe to monitor loading (bottom panel ).
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and APP2 /2/APLP12 /2) by crossing the respective single mutants
(see Materials and Methods for details). To obtain APP2 /2/
APLP22 /2 mice, animals deficient for APLP2 and heterozygous
for APP (APLP22 /2/APP1/2) were intercrossed and expected to
yield 25% offspring deficient for both proteins. When we geno-
typed the offspring at weaning (;4 weeks of age) initially none and,
after analysis of a larger sample of 355 mice, only a single surviving
double mutant was found (Table 1A), suggesting that a combined
deficiency of APP/APLP2 is lethal either during development or
within the first weeks after birth. Analysis of the genotype distri-
bution of offspring at E19 and shortly after birth (P0) showed that
almost the theoretically expected number of double mutants (21%
of 131 animals screened; Table 1A) survived until this time point.
A smaller sample of 26 mice was analyzed at postnatal day 1 (P1),
however, only two APP2 /2/APLP12 /2 mice were found (one of
which died at P2 and the other after 4 weeks) indicating postnatal
lethality, predominantly within the first day after birth.
Analogously, APLP11/2/APLP22 /2 mice were intercrossed, and
the offspring were genotyped at weaning. As seen for APP2 /2/
APLP22 /2 mice, a combined APLP1/APLP2 deficiency proved
lethal, in this case with 100% penetrance. Among 326 animals
analyzed at weaning, not a single surviving double mutant was found
(Table 1B). A smaller sample of pups was screened shortly after
birth (P0), and another set on P1 (Table 1B). Whereas APLP12 /2/
APLP22 /2 mice were born at normal Mendelian frequency (29% of
171 animals), no surviving double mutants were found at P1, indi-
cating that a combined APLP1/APLP2 deficiency results in lethality
within the first day after birth. These results demonstrate that APP
family members serve essential but at least partially redundant func-
tions in vivo and corroborate a key physiological role for APLP2.
To our surprise, APP2 /2/APLP12 /2 mice generated in a sim-
ilar manner were viable, fertile, and showed no apparent abnor-
malities, apart from a body weight deficit comparable to that of
single mutants, until at least 18 months of age. This unexpected
finding that not all three possible combinations of the single mu-
tants results in a lethal phenotype has crucial implications for the
specific and redundant functions exerted by APP family members
(see Discussion).
The key physiological function or functions of APLP2 are fur-
ther supported by recent preliminary data demonstrating postnatal
lethality for APP2 /2/APLP12 /2/APLP21/2 mice, which suggests
haploinsufficiency for the remaining single APLP2 allele. In an
attempt to ultimately generate triple knock-outs, which should
theoretically be feasible by intercrossing APP2 /2/APLP12 /2/
APLP21/2 mice, we set up appropriate matings (see Material and
Methods) that were expected to yield 25% offspring of the respective
(APP2 /2/APLP12 /2/APLP21/2) genotype. Among 350 animals
screened at weaning, we found only four APP2 /2/APLP12 /2/
APLP21/2 mice (1% instead of the expected 25%). As observed
for double mutants (see below) APP2 /2/APLP12 /2/APLP21/2
mice showed (when analyzed on P0) no apparent histopathological
abnormalities (data not shown). The surviving animals were se-
verely impaired in breeding, and we have so far been unable to
obtain any litters from these mice. Again, lethality occurred post-
natally, because an APP2 /2/APLP12 /2/APLP21/2 allele fre-
quency of 27% was found in a smaller sample of mice, analyzed
shortly after birth (data not shown). We conclude from these data
that the presence of a single APLP2 allele in the absence of other
APP family members is not sufficient for survival.
Analysis of APP/APLP expression in double mutants
We then asked whether the viable phenotype of APP2 /2/
APLP12 /2 mice may be attributed to a compensatory upregula-
Figure 3. Western blot analysis of APP/APLP expression in single and
double mutants. A, Total brains of newborn APP 2 /2 (lane 9), APLP2 2 /2
(lane 7 ), and wt (lane 8) mice and in addition brains of newborn mice
generated by intercrossing heterozygous APP 1/2/APLP1 2 /2 mice (lanes
1–6 ) were homogenized, and equal amounts of protein (20 mg/ lane) were
resolved on 8% PAA gels. From each blot the bottom half was cut off and
probed with an Actin-specific antibody to monitor loading (second row of
each panel). Top, Note that probing with an antiserum specific for APLP2
(D2II) showed no major alterations of APLP2 expression in animals of
different APP/APLP1 genotype compared to wt levels (lane 8). Bottom,
Probing with an APP-specific antibody (22C11) showed comparable
amounts of total APP expression in APLP1 2 /2 (lanes 1, 2) and wt (lane 8)
mice. The seemingly higher expression of APP in APLP2 2 /2 mice (lane 7 )
is attributable to unequal loading as evidenced by more intense actin
staining. As expected, APP expression was abolished in APP 2 /2 single
mutants (lane 9) and APP 2 /2/APLP1 2 /2 double mutants (lanes 5, 6 ). Note
that in heterozygous APP 1/2/APLP1 2 /2 mice APP expression is reduced
to ;50%, arguing against a compensatory upregulation of APP expression.
B, Total brains of newborn pups obtained from heterozygous APLP2 1/2/
APLP1 2 /2 intercrosses were homogenized, and equal amounts of protein
(20 mg/ lane) were separated on a 8% PAA gel. Top, Probing with an
APP-specific antibody (22C11) showed similar amounts of total APP ex-
pression in both viable APLP1 1/2/APLP2 2 /2 heterozygotes (lanes 3, 4 ) or
in lethal APLP1 2 /2/APLP2 2 /2 double knock-outs (lanes 5, 6 ), compared
to the amount of APP expression in APLP2 2 /2 single mutants (lanes 1, 2)
or in a wt control (lane 7 ). Note that no significant compensatory upregu-
lation of APP expression was found. Bottom, Probing with an antiserum
specific for APLP1 (CT11) showed similar APLP1 expression levels in
4
APLP2 2 /2 mice (lanes 1, 2) compared to the wt control. Note that in
heterozygous APLP1 1/2/APLP2 2 /2 animals (lanes 3, 4 ) expression is
reduced to ;50% and abolished in APLP1 2 /2/APLP2 2 /2 double mutants
(lanes 5, 6 ). Genotypes of animals analyzed are as indicated above blot
panels.
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tion of APLP2 (Fig. 3). Western blot analysis of brain homogenates
prepared from newborn mice showed APLP2 levels comparable to
those found in single mutants or wt animals (Fig. 3A, top) suggest-
ing that basal wt-APLP2 levels are not limiting for survival. More
subtle or region-specific alterations in APLP2 expression cannot be
ruled out, however. Likewise, APP protein levels were not upregu-
lated in heterozygous, viable APP1/2/APLP12 /2 littermates,
showing an ;50% reduction of APP as compared to APP1/1/
APLP12 /2 single knock-outs (Fig. 3A, bottom). We then deter-
mined whether in the lethal APLP22 /2/APLP12 /2 double knock-
out, expression of the remaining third family member, APP, is
altered. Both Northern (data not shown) and Western blot analysis
failed to reveal changes in the expression level of APP in the brains
of both newborn viable APLP22 /2/APLP11/2 pups and of
APLP22 /2/APLP12 /2 littermates that would have died within
the next hour (Fig. 3B, top). However, APLP1 expression was
found to be reduced to ;50% of wt level in viable APLP22 /2/
APLP11/2 heterozygous newborns (Fig. 3B, bottom). Thus, a loss
of APP/APLP family members does not cause compensatory up-
regulation of related family members in double knock-outs.
Gross and histopathological analysis of double mutants
Newborn double mutants were initially (for several hours) indis-
tinguishable from their littermates and were able to suckle. Be-
Table 1A. Genotype analysis of offspring obtained from APP/APLP2 matings
Survival rates of APP/APLP2 double mutants reveal postnatal lethality. At E19, or shortly after birth (at P0), a total of 131 animals obtained from parents of the indicated
genotypes were examined. At this time point double knock-out animals were obtained at about the expected frequency (21%). Of 26 mice analyzed at P1 only two
APP2/2/APLP12/2 mice were found, one of which died at P2 and the other at the age of 4 weeks. At weaning only one APP2/2/APLP22/2 double knock-out mouse of 355
animals examined was found that has so far survived for 13 months.
Table 1B. Genotype analysis of offspring obtained from APLP1/APLP2 matings
Survival rates of APLP1/APLP2 double mutants reveal postnatal lethality. Shortly after birth (at P0) a total of 171 newborn animals obtained from parents of the indicated
genotypes were examined. At this early time point double knock-out animals were obtained at a normal frequency (29%), indicating that APLP1/APLP2s are not essential for
embryonic development. Note that no APLP22/2/APLP12/2 double knock-out mice were found among 28 animals examined at P1 or among 326 animals analyzed at weaning.
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tween ;5 and 15 hr after birth, however, they had no or less milk
in their stomachs, appeared weaker, became pale, and died. From
the observation of several litters of mice of both types of lethal
double mutants, we have no evidence for motor paralysis or overt
seizure activity. To address the cause of the early postnatal lethal-
ity observed in APLP22 /2/APLP12 /2 and APLP22 /2/APP2 /
2double knock-outs, we used various histological approaches to
examine newborn double mutants, as compared to APLP22 /2
single mutants and wt controls. No obvious abnormalities were
observed after macroscopic examination, revealing normal sizes of
the head, face, and body postnatally. Hematoxylin–eosin-stained
sections of internal organs also did not show any abnormalities. In
particular, no malformations of the palate, esophagus, stomach,
intestine, colon, and rectum were found that could result in im-
paired feeding behavior. Moreover, meconium was present in the
intestine of all mutants. Furthermore, cranial nerves implicated in
feeding, including trigeminal ganglion and facial motor nucleus,
were present and appeared of normal size. The heart and lungs
appeared normal in maturity and size, which argues against an
impairment of cardiopulmonary function as the cause of lethality,
however alterations in the efferent autonomic innervation of the
heart cannot be excluded. None of the organs examined (thyroid,
thymus, spleen, pancreas, liver, kidneys, bladder, testis, and ova-
ries) showed differences in size or histopathological abnormalities
in both types of double mutants, or single mutants, compared to wt
controls (data not shown).
In the brain no signs of increased cell death were found, as
evidenced by pyknotic nuclei in Nissl-stained sections or by
TUNEL staining (Fig. 4). The neocortex showed the normal lay-
ered structure, and cortical neurons were of normal appearance.
CA1 through CA3 regions and the dentate gyrus of the hippocam-
pus appeared normal, based on Nissl staining pattern and MAP-II
and synaptophysin immunohistochemistry, indicating that lack of
APLP2 either in combination with a deficiency for APP, or
APLP1, respectively, did not affect hippocampal architecture and
cell /neurite density (Fig. 4). GFAP immunohistochemistry re-
vealed no signs of gliosis (data not shown).
Because APLP2 has been suggested to play a role in axon
outgrowth in the olfactory system, where it is highly expressed in
olfactory sensory neurons and axon terminal glomeruli (Thinaka-
ran et al., 1995a), we analyzed the olfactory system of both types of
double mutants. However, the distribution and density of neurons
in the olfactory bulb, as well as the number and thickness of
neuron-specific tubulin-positive axon bundles, were not found to be
different between the lines studied (data not shown). No differ-
ences were observed in size and nerve cell density of brainstem
nuclei (data not shown).
APP undergoes fast axonal trafficking to presynaptic terminals
(Tienari et al., 1996) and has been detected in rab5-containing
(Ikin et al., 1996) and clathrin-coated vesicles (Nordstedt et al.,
1993), organelles that are likely to be involved in endocytosis. To
assess whether a lack of APP family members affected synaptic
architecture, we examined by electron microscopy coronal sections
of the cortex and the brainstem from newborn double mutants and
controls (see Fig. 5 for representative images). Inspection of many
electron micrographs revealed in both types of lethal double mu-
tants (Fig. 5B,C) mature synapses in the brainstem, at densities
similar to that found in wt controls (Fig. 5A). In contrast, predom-
inantly immature synapses were detectable in the developing cor-
tices of these mice (data not shown). Again, no apparent differ-
ences in synapse densities could be detected between sections from
wt and the lethal double mutants (data not shown). Also, no
obvious changes were found in the ultrastructure of the nerve
terminals (Fig. 5). We therefore conclude that, at least with regard
to these morphological aspects, synapse formation proceeds appar-
ently normal in the brainstem of mutant animals. We also consider
neuromuscular deficits as an unlikely cause of lethality in double
mutants because some of us have addressed this question in a
previous study investigating APP/APLP2 double knock-outs (von
Koch et al., 1997).
Viability of primary neuronal cultures derived from
single and combined mutants
Viability of cortical neurons derived either from APLP22 /2 single
mutants or from both types of lethal double mutants (APP2 /2/
APLP22 /2 and APLP12 /2/APLP22 /2) was investigated by
counting viable neurons on gridded coverslips after plating (DIV 1)
and again after 7 d in culture (DIV 7; Fig. 6). No significant
differences relative to wt neurons were detectable for any of the
mutants analyzed, indicating that under the culture conditions
used, loss of endogenous APLP2 alone, or in combination with
APLP1 (see Fig. 6A for APLP12 /2/APLP22 /2) or with APP (see
Fig. 6B for APP2 /2/APLP22 /2), respectively, does not affect
neuronal survival. Moreover, we saw no significant differences in
plating efficiency of viable neurons between wt and mutant cultures
on DIV 1 (data not shown), indicating that lack of APP family
members did not affect the viability of major neuronal subpopula-
tions in these cultures.
Survival of neuronal cultures derived from single or
combined mutants against excitotoxic stress
Studies by Mattson et al. (1993) and Mattson (1994) have demon-
strated that primary neuronal cultures can be protected from
glutamate-induced excitotoxicity by addition of exogenous secreted
forms of human APP (sAPP) to the culture medium. We have
previously shown that APP-deficient mice are hypersensitive to
seizures induced by the glutamate receptor agonist kainate, al-
though the amount of tissue damage was similar to that observed
for wt animals (Steinbach et al., 1998). However, using primary
neuronal cultures derived from APP mutant mice, we and others
(Steinbach et al., 1998; White et al., 1998) have been unable to show
differences in the glutamate sensitivity of APP-deficient neurons.
To unravel whether endogenous APP plays any role in the protec-
tion of neurons against glutamate excitotoxicity and whether the
related APLPs may compensate for such a protection by APP, we
compared the survival of neurons derived from single APP family
mutants and from lethal mutants deficient for a combination of
APLP2/APP, or APLP2/APLP1, respectively. Two sets of exper-
iments were performed. We first investigated the response of
neurons prepared from single embryos obtained by intercrossing
heterozygous APP1/2/APLP22 /2 mice and as controls, neurons
prepared from wt embryos of 129Sv(ev)xC57BL/6 matings (Fig.
7A,C). Second, we analyzed neurons of embryos derived from
intercrosses of APLP11/2/APLP22 /2 mice in comparison to wt
neurons of 129Sv(ev)xC57BL/6 matings (Fig. 7B,D). Cortical neu-
rons were used because sufficient numbers of cells can be obtained
from individual cortices and moreover, this cell type has previously
been shown to be protected from glutamate excitotoxicity by (hu)
sAPP (Mattson et al., 1993). Cortical neurons cultured under
serum-free conditions for 15 d in vitro were treated with increasing
amounts of glutamate (10–100 mM) for 24 hr, and their survival was
assessed by MTT assays. This resulted in a glutamate
concentration-dependent reduction in cell survival for all cultures
examined. Neither APLP2-deficient neurons nor APP2 /2/
APLP22 /2 double knock-out cultures differed, however, signifi-
cantly in their survival rates compared to wt control neurons at any
glutamate concentration used (Fig. 7B). Likewise, APLP12 /2/
APLP22 /2 double knock-out cultures showed similar survival
rates as APLP22 /2 single knock-outs or wt control cultures (Fig.
7A). To test for possible differences in the response kinetics of the
various mutants we investigated cell survival at 1, 3, and 24 hr after
addition of a constant amount of 50 mM glutamate (Fig. 7C,D for 1
and 3 hr, Fig. 7A,B for 24 hr time point). Again, no significant
differences for both sets of mutants compared to wt neurons were
found at any time point investigated. As expected from these
results, we were also unable to detect significant differences when
we tested the whole panel of single mutants APP2 /2, APLP22 /2,
and APLP12 /2 relative to wt controls (data not shown).
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We have conducted MTT assays to monitor cell death in re-
sponse to glutamate challenge. Because no difference was found
between mutants and wt neurons either at different concentrations
or after different length of exposure to glutamate, we did not
extensively investigate the actual mode of cell death. Apoptotic cell
death has been reported in cultures of cortical neurons when
assayed late (18–24 hr) after exposure to excitotoxins (Tenneti and
Lipton, 2000). After incubation with 50 mM glutamate for 24 hr we
Figure 4. Characterization of mutants by immunocytochemistry on brain sections. Histological analysis of the cortex and hippocampus from age-matched
newborn wild-type, APLP2 2 /2, and double knock-out mice lacking either APLP2/APLP1 or APLP2/APP revealed no apparent anomalies in any of the
mutants examined. Pictures show frontal sections of parietal cortex (a–d) and hippocampus (a9–d9) from wild-type (a), APLP2 2 /2 (b), APP 2 /2/
APLP2 2 /2 (c), and APLP1 2 /2/APLP2 2 /2(d) knock-out mice. Shown are Nissl stains and immunohistochemistry with antibodies directed against
synaptophysin (Syn) and MAP-II, as well as TUNEL stains. Scale bars: d, d9, 50 mm (applies to all panels). The cortical layers are indicated as: MZ,
marginal zone; CP, cortical plate; SP, subplate; IZ, intermediate zone. The hippocampal structures are indicated as follows: St.O, stratum oriens; P, CA1
pyramidal cells; St.R, stratum radiatum; St.M, stratum moleculare; DG, dentate gyrus granule cells. The arrows mark apoptotic nuclei.
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detected predominantly apoptotic cell death to a similar extent in
both wt and mutant cortical cultures, as evidenced by staining with
fluorescent chromatin dyes (data not shown). It is conceivable that
a mutation could have a differential effect on the type of cell death,
altering either necrotic or apoptotic responses that may contribute
to overall amounts of cell death depending on the specific dose and
duration of the insult (Nicotera et al., 1999). Because we saw no
shift in the kinetics of overall cell death (as measured by MTT, see
Fig. 7) we consider that as unlikely. Moreover, for none of the
groups we detected any significant differences in the endpoint of
maximal values of cell death. In summary, these findings indicate
that cortical neurons deficient in either individual APP family
members or doubly deficient for APP/APLP2 or APLP1/APLP2,
respectively, do not differ significantly in their ability to survive
glutamate-induced excitotoxic insults.
DISCUSSION
This paper investigates the phenotype of APLP1 knock-out mice
and a complete set of double mutants comprising all combinations
of known APP family members. A summary of our findings is given
in Table 2. To analyze the physiological role of the nervous system-
specific APLP1 protein, we have generated APLP12 /2 mice that
were viable and fertile, but revealed a body weight deficit, similar to
that observed for APP knock-out mice (Zheng et al., 1995; Tremml
et al., 1997; Magara et al., 1999). Thus, both APP and APLP1
appear to play a role in postnatal somatic growth. At least for
APLP1-deficient mice, this phenotype might reflect a neural defi-
cit, because APLP1 expression is restricted to the nervous system.
Other abnormalities, including those observed for APP2 /2 mice,
were absent in APLP1-deficient mice, suggesting either functional
compensation by other family members or distinct functions for
APLP1 and APP.
Postnatal lethality of double mutants
In contrast to the minor phenotype of mice singly deficient for
individual APP family members, two of three double mutants
generated in this study (APP2 /2/APLP22 /2 and APLP12 /2/
APLP22 /2) proved perinatally lethal, indicating essential but par-
tially redundant functions within the gene family (Table 2). Our
findings that APP2 /2/APLP22 /2 mice die shortly after birth are
in agreement with previous results from von Koch et al. (1997),
who had crossed the same line of APLP22 /2 mice used here to the
APP2 /2 line generated by Zheng et al. (1995). Interestingly, we
observed an almost complete penetrance of early postnatal lethal-
ity for our strain of APP2 /2/APLP22 /2 mice, whereas 26% of
double mutants generated by von Koch et al. (1997) survived well
into adulthood. This difference in penetrance is likely attributable
to the respective APP knock-out strains, which differ in the tar-
geted deletion introduced into the APP locus and in the composi-
tion of genetic background alleles. Because the phenotypes of both
APP single knock-out lines are largely congruent, it appears more
likely that differences in the genetic backgrounds affected pen-
etrance (Mu¨ller, 1999).
Given the similarities of the phenotypes of the two lethal double
mutants (APP2 /2/APLP22 /2 and APLP12 /2/APLP22 /2), i.e.,
death within the first day or days in the absence of gross morpho-
logical anomalies, a common underlying mechanism seems likely,
although the actual cause is presently unknown. Because APLP1
is, unlike the ubiquitously expressed APP and APLP2 proteins,
restricted to the nervous system, it is conceivable that the cause of
lethality resides, at least for APLP12 /2/APLP22 /2 mice, in the
nervous system. This hypothesis gains further support from recent
studies on the Caenorhabditis elegans homolog APL-1 by Li et al.
Figure 5. Ultrastructure of brainstem synapses from single or combined mutants. Comparison of the morphology of synapses in brainstem ultrathin
sections from newborn mice revealed no obvious changes in the ultrastructure of the nerve terminals in mutant compared to wt mice. Shown are electron
micrographs of representative active zones obtained from wt (A), APLP2 2 /2/APP 2 /2 (B), and APLP2 2 /2/APLP1 2 /2 (C) samples processed as
described in Materials and Methods. At the presynaptic site mutants and control mice showed comparably sized vesicle clouds, including docked vesicles
in close proximity to the membrane. Electron dense postsynaptic specializations were clearly detectable in both double mutants.
Figure 6. Viability of cortical neurons from single or combined mutants.
Neuronal viability was similar to that of wt neurons in APLP2 2 /2 single
mutants (A, B) or both types of double mutants. A, APLP2 2 /2/APLP1 2 /2
double mutants. B, APLP2 2 /2/APP 2 /2 double mutants. Cortical neurons
were obtained from individual embryos, as described in Materials and
Methods. Viable neurons were counted using gridded coverslips once at
DIV 1 (set as 100%) and again on DIV 7. For each embryo ;240–360
neurons were counted, and two or three embryos were analyzed for each
genotype. Values represent mean neuron counts obtained for mice of the
indicated genotypes 6 SEM, normalized to initial values on DIV 1.
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(Daigle and Li, 1993; Hornsten et al., 1999). Most interestingly, a
knock-out of the ubiquitously expressed apl-1 gene proved lethal in
C. elegans, but could be rescued by transgenic expression of APL-1
in neurons, indicating lethal neuronal deficits in the absence of
APL-1 (Hornsten et al., 1999).
APP family members could be compensating for each other by
binding to and stimulating a common, as yet unidentified receptor.
Alternatively, APP/APLPs might act themselves as receptors for a
common ligand. Several proteins containing phosphotyrosine-
binding (PTB) domains (e.g., Fe65- and X11-family proteins) in-
teract with the intracellular C-terminal domain of APP/APLPs,
including the cytoplasmic adapter protein Dab1 (Homayouni et al.,
1999). Dab1 is involved in the reelin (Reln) signal transduction
pathway, which directs cell positioning in the developing CNS
(Rice and Curran, 1999). Our histopathological analysis of single
or combined APP/APLP mutants failed to reveal, however, alter-
ations in the formation of laminated brain structures, typically seen
in Dab12 /2 and Reln2 /2 mice (D. Rice, R. Homayouni, M.
Sheldon, and T. Curran, personal communication). Interestingly,
mice lacking cyclin-dependent kinase 5 (cdk5), a kinase known to
phosphorylate tau protein implicated in Alzheimer’s disease, also
display late embryonic or perinatal lethality. In contrast to APP/
APLP mutants they exhibit, however, lamination defects similar to
Dab12 /2 and Reln2 /2 mice (Ohshima et al., 1996). Recently, APP
has been shown to have antiapoptotic effects in a neuroblastoma
(B103) cell line challenged with apoptosis-inducing insults (Xu et
al., 1999). It will therefore be interesting to see whether neurons
derived from APP/APLP knock-out mice are, accordingly, more
sensitive to apoptotic challenge. In this study, however, no increase
in the amount of spontaneous apoptosis was detectable, as evi-
denced by normal, low levels of TUNEL-positive cells in the brains
of newborn mutant mice. It is evident from the lack of obvious
morphological abnormalities that a more detailed analysis is nec-
essary, addressing for example possible deficits in synaptogenesis
and/or electrophysiological alterations.
Neuronal survival and response to
glutamate-induced excitotoxicity
One aim of this work was to assess the role of endogenous APP
family members for neuronal survival and protection against exci-
Figure 7. Susceptibility of neurons from single or combined mutants to glutamate excitotoxicity. Cortical neurons from single mutants, heterozygotes, or
double mutants showed no difference in their resistance to glutamate toxicity compared to wt neurons. Primary cortical neurons of the indicated genotypes
were cultivated for 15 d before they were treated with glutamate, and their survival was analyzed by MTT assays. A, B, Cultures were exposed to different
glutamate concentrations (10, 25, 50, 100 mM) for 24 hr. C, D, Glutamate (50 mM) was applied for 1 and 3 hr. MTT measurements were performed
immediately after the glutamate exposures. Neurons from embryos of the respective genotypes were generated as described in Materials and Methods.
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totoxic stress that may contribute to the pathology of Alzheimer’s
disease. This study clearly demonstrates that cortical neurons,
deficient for either APLP2 alone, or doubly deficient for APLP2/
APP, or APLP2/APLP1 respectively, show unaltered survival rates
under basal culture conditions, which confirms and extends previ-
ous studies in APP or APLP2 single knock-outs (Harper et al.,
1998; Steinbach et al., 1998; White et al., 1998, 1999a). These data
suggest that the presumed neurotrophic activities of endogenous
APP/APLP proteins are not essential for survival, at least as long
as one APP family member is still expressed. Perez et al. (1997)
have reported a small (;20%) difference in the rate of survival of
hippocampal neurons lacking APP, contrasting with normal sur-
vival rates in this study. This discrepancy may either be attributable
to differences in culture conditions or alternatively, endogenous
APP may play a greater role in neurons derived from the hip-
pocampus, a region especially vulnerable in AD.
Several studies suggested that APP (and possibly also APLPs)
may exert neuroprotective functions. In vitro, exogenously added
(hu)sAPP can protect cortical and hippocampal neurons against
the toxic effects of glutamate and Ab peptide, and may modulate
K1 channels and suppress NMDA receptor-mediated ion currents
(Mattson et al., 1993; Furukawa et al., 1996; Furukawa and Matt-
son, 1998). Ca21 influx via NMDA channels has in turn been
implicated as a major mechanism underlying excitotoxic cell death.
In vivo, moderate overexpression of huAPP in transgenic mice
confers resistance to kainate-induced and chronic forms of excito-
toxicity (Mucke et al., 1994; Masliah et al., 1997). The role of
endogenous APP for neuroprotection seems less clear. We have
previously shown that APP knock-out mice are more vulnerable to
kainate-induced seizures, however no increase in the amount of
tissue damage or reduced survival responses of primary neurons
were found (Steinbach et al., 1998; White et al., 1998). To assess
whether compensation by APLPs may have alleviated excitotoxic-
ity, we investigated in this study the response of cortical neurons
derived from double mutants against glutamate excitotoxicity. Our
data, demonstrating no significant difference in the response of
cortical neurons derived from APLP22 /2 single mutants or
APP2 /2/APLP22 /2 and APLP12 /2/APLP22 /2 double mutants,
as compared to wt neurons, do not support a prominent protective
function of endogenous APP/APLPs against glutamate toxicity in
vitro. We cannot exclude, however, that because of experimental
variability (SEM of ;10–15% of variable) more subtle effects may
have been masked. Conversely, it is also possible that the third APP
family member might still exert compensatory effects. It remains to
be seen, whether neurons from APLP22 /2 single mutants, or
double mutants, will show altered responses to other forms of
metabolic stress, including Ab-mediated toxicity. In vivo, endoge-
nous APP/APLPs secreted locally might reach higher concentra-
tions and might play a role in ameliorating chronic forms of
excitotoxic and oxidative stress that have been implicated as factors
contributing to AD pathology (Furukawa and Mattson, 1998;
White et al., 1998).
Redundancy within the gene family
Interestingly, lack of APLP2 in combination with a deficiency of
either APP or APLP1 was perinatally lethal, whereas the third
double mutant, APP2 /2/APLP12 /2 was viable and apparently
normal (Table 2). These data corroborate a key physiological role
for APLP2 and indicate redundancy between APLP2 and both
other family members. The viability of APP2 /2/APLP12 /2 mice
could not be explained by an upregulation of APLP2, because
APLP2 expression was unaltered (Fig. 3). Likewise, viable het-
erozygous littermates of lethal double mutants showed no upregu-
lation of APP/APLP expression. Even in the absence of APLP2
upregulation, viability of APP2 /2/APLP12 /2 mice might still be
attributable to compensation by APLP2, a view that is further
supported by the postnatal lethality of APP2 /2/APLP12 /2/
APLP21/2 mice. It will be interesting to see whether lack of the
entire APP family will result in an even more pronounced
phenotype.
The unexpected finding that APP2 /2/APLP12 /2 mice are via-
ble has also crucial implications for the specific physiological func-
tions exerted by APP and APLP2. So far, it has been widely
assumed (von Koch et al., 1997; Steinbach et al., 1998; White et al.,
1998) that both proteins may serve primarily overlapping functions
because (1) APP and APLP2 are highly homologous, (2) they are
similarly processed, (3) they are expressed in a virtually overlap-
ping pattern, and (4) deficiency of both proteins results is a syn-
thetic lethal phenotype suggesting functional redundancy. This
Table 2. Phenotypes of APP family knock-outs
Genotype Phenotype Reference
Single mutants
APP2/2 Viable and fertile Zheng et al.
Reduced body weight Mu¨ller et al.
Reduced grip strength Li et al.
Reduced locomotor activity
Alterations in sensorimotor development Tremml et al.
Commissure defects Magara et al.
Hypersensitivity to epileptic seizures Steinbach et al.
APLP12/2 Viable and fertile This paper
Reduced body weight
APLP22/2 Viable and fertile von Koch et al.
No apparent abnormalities
Double mutants
APLP22/2, APP2/2 Perinatally lethal This paper
No histopathological anomalies von Koch et al.
APLP22/2, APLP12/2 Perinatally lethal This paper
No histopathological anomalies
APLP12/2, APP2/2 Viable and fertile This paper
Reduced body weight
APLP12/2, APP2/2, APLP21/2 Perinatally lethal This paper
No histopathological anomalies
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view, however, is challenged by our data showing that double
mutants obtained by crosses of APP2 /2 or APLP22 /2 single
mutants with APLP12 /2 mice have clearly different phenotypes,
being either viable (APP2 /2/APLP12 /2) or lethal (APLP22 /2/
APLP12 /2). We thus provide genetic evidence that APP and
APLP2 must serve, besides overlapping functions, also at least
some distinct, nonredundant functions in vivo.
REFERENCES
Banker G, Goslin K (1998) Culturing nerve cells. Cambridge, MA: MIT.
Daigle I, Li C (1993) apl-1, a Caenorhabditis elegans gene encoding a
protein related to the human beta-amyloid protein precursor. Proc Natl
Acad Sci USA 90:12045–12049.
Fox WM (1965) Reflex-ontogeny and behavioural development of the
mouse. Anim Behav 13:234–241.
Furukawa K, Mattson MP (1998) Secreted amyloid precursor protein al-
pha selectively suppresses N-methyl-D-aspartate currents in hippocampal
neurons: involvement of cyclic GMP. Neuroscience 83:429–438.
Furukawa K, Barger SW, Blalock EM, Mattson MP (1996) Activation of
K1 channels and suppression of neuronal activity by secreted beta-
amyloid-precursor protein. Nature 379:74–78.
Harper SJ, Bilsland JG, Shearman MS, Zheng H, Van der Ploeg L,
Sirinathsinghji DJ (1998) Mouse cortical neurones lacking APP show
normal neurite outgrowth and survival responses in vitro. NeuroReport
9:3053–3058.
Homayouni R, Rice DS, Sheldon M, Curran T (1999) Disabled-1 binds to
the cytoplasmic domain of amyloid precursor-like protein 1. J Neurosci
19:7507–7515.
Hornsten A, Hausmann RE, Li C (1999) The C. elegans amyloid precursor-
related gene has an essential function. Soc Neurosci Abstr 25:2054.
Ikin AF, Annaert WG, Takei K, De Camilli P, Jahn R, Greengard P,
Buxbaum JD (1996) Alzheimer amyloid protein precursor is localized
in nerve terminal preparations in Rab5-containing vesicular organelles
distinct from those implicated in the synaptic vesicle pathway. J Biol
Chem 271:31783–31786.
Li ZW, Stark G, Go¨tz J, Ru¨licke T, Gschwind M, Huber G, Mu¨ller U,
Weissmann C (1996) Generation of mice with a 200-kb amyloid precur-
sor protein gene deletion by Cre recombinase-mediated site-specific
recombination in embryonic stem cells. Proc Natl Acad Sci USA
93:6158–6162.
Lorent K, Overbergh L, Moechars D, De Strooper B, Van Leuven F, Van
den Berghe H (1995) Expression in mouse embryos and in adult mouse
brain of three members of the amyloid precursor protein family, of the
alpha-2-macroglobulin receptor/ low density lipoprotein receptor-related
protein and of its ligands apolipoprotein E, lipoprotein lipase, alpha-2-
macroglobulin and the 40,000 molecular weight receptor-associated pro-
tein. Neuroscience 65:1009–1025.
Magara F, Mu¨ller U, Li ZW, Lipp HP, Weissmann C, Stagljar M, Wolfer
DP (1999) Genetic background changes the pattern of forebrain com-
missure defects in transgenic mice underexpressing the beta-amyloid-
precursor protein. Proc Natl Acad Sci USA 96:4656–4661.
Masliah E, Westland CE, Rockenstein EM, Abraham CR, Mallory M,
Veinberg I, Sheldon E, Mucke L (1997) Amyloid precursor proteins
protect neurons of transgenic mice against acute and chronic excitotoxic
injuries in vivo. Neuroscience 78:135–146.
Mattson MP (1994) Secreted forms of beta-amyloid precursor protein
modulate dendrite outgrowth and calcium responses to glutamate in
cultured embryonic hippocampal neurons. J Neurobiol 25:439–450.
Mattson MP (1997) Cellular actions of beta-amyloid precursor protein
and its soluble and fibrillogenic derivatives. Physiol Rev 77:1081–132.
Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel RE
(1993) Evidence for excitoprotective and intraneuronal calcium-
regulating roles for secreted forms of the beta-amyloid precursor protein.
Neuron 10:243–254.
Mosmann T (1983) Rapid colorimetric assay for cellular growth and sur-
vival: application to proliferation and cytotoxicity assays. J Immunol
Meth 65:55–63.
Mucke L, Masliah E, Johnson WB, Ruppe MD, Alford M, Rockenstein
EM, Forss PS, Pietropaolo M, Mallory M, Abraham CR (1994) Synap-
totrophic effects of human amyloid beta protein precursors in the cortex
of transgenic mice. Brain Res 666:151–167.
Mu¨ller U (1999) Ten years of gene targeting: targeted mouse mutants,
from vector design to phenotype analysis. Mech Dev 82:3–21.
Mu¨ller U, Cristina N, Li ZW, Wolfer DP, Lipp HP, Ru¨licke T, Brandner S,
Aguzzi A, Weissmann C (1994) Behavioral and anatomical deficits in
mice homozygous for a modified beta-amyloid precursor protein gene.
Cell 79:755–765.
Nicotera P, Leist M, Manzo L (1999) Neuronal cell death: a demise with
different shapes. Trends Pharmacol Sci 20:46–51.
Nordstedt C, Caporaso GL, Thyberg J, Gandy SE, Greengard P (1993)
Identification of the Alzheimer b/A4 amyloid precursor protein in
clathrin-coated vesicles from PC12 cells. J Biol Chem 268:608–612.
Ohshima T, Ward JM, Huh C-G, Longenecker G, Veerana, Pant HC,
Brady RO, Martin LJ, Kulkarni AB (1996) Targeted disruption of the
cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neu-
ronal pathology and perinatal death. Proc Natl Acad Sci USA
93:11173–11178.
Paliga K, Peraus G, Kreger S, Durrwang U, Hesse L, Multhaup G, Masters
CL, Beyreuther K, Weidemann A (1997) Human amyloid precursor-like
protein 1 - cDNA cloning, ectopic expression in cos-7 cells and identifi-
cation of soluble forms in the cerebrospinal fluid. Eur J Biochem
250:354–363.
Perez RG, Zheng H, Van der Ploeg LH, Koo EH (1997) The beta-
amyloid precursor protein of Alzheimer’s disease enhances neuron via-
bility and modulates neuronal polarity. J Neurosci 17:9407–9414.
Rice DS, Curran T (1999) Mutant mice with scrambled brains: under-
standing the signaling pathways that control cell positioning in the CNS.
Genes Dev 3:2758–2773.
Ruffner H, Reis LF, Na¨f D, Weissmann C (1993) Induction of type I
interferon genes and interferon-inducible genes in embryonal stem cells
devoid of interferon regulatory factor 1. Proc Natl Acad Sci USA
90:11503–11507.
Sandbrink R, Masters CL, Beyreuther K (1994) Complete nucleotide
and deduced amino acid sequence of rat amyloid protein precursor-
like protein 2 (APLP2/APPH): two amino acids length difference to
human and murine homologues. Biochimica et Biophysica Acta
1219:167–170.
Simons M, Ikonen E, Tienari PJ, Cid-Arregui A, Monning U, Beyreuther
K, Dotti CG (1995) Intracellular routing of human amyloid protein
precursor: axonal delivery followed by transport to the dendrites. J Neu-
rosci Res 41:121–128.
Slunt HH, Thinakaran G, Von KC, Lo AC, Tanzi RE, Sisodia SS (1994)
Expression of a ubiquitous, cross-reactive homologue of the mouse
beta-amyloid precursor protein (APP). J Biol Chem 269:2637–2644.
Sprecher CA, Grant FJ, Grimm G, O’Hara PJ, Norris F, Norris K, Foster
DC (1993) Molecular cloning of the cDNA for a human amyloid pre-
cursor protein homolog: evidence for a multigene family. Biochemistry
32:4481–4486.
Steinbach JP, Mu¨ller U, Leist M, Li Z-W, Nicotera P, Aguzzi A (1998)
Hypersensitivity to Seizures in b-amyloid precursor protein deficient
mice. Cell Death Diff 5:858–866.
Tenneti L, Lipton SA (2000) Involvement of activated caspase-3-like pro-
teases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neu-
rons. J Neurochem 74:134–142.
Tienari PJ, De Strooper B, Ikonen E, Simons M, Weidemann A, Czech C,
Hartmann T, Ida N, Multhaup G, Masters CL, Van Leuven F, Beyreuther
K, Dotti C (1996) The b-amyloid domain is essential for axonal sorting
of amyloid precursor protein. EMBO J 15:5218–5229.
Thinakaran G, Sisodia SS (1994) Amyloid precursor-like protein 2
(APLP2) is modified by the addition of chondroitin sulfate glycosami-
noglycan at a single site. J Biol Chem 269:22099–22104.
Thinakaran G, Kitt CA, Roskams AJ, Slunt HH, Masliah E, von Koch C,
Ginsberg SD, Ronnett GV, Reed RR, Price DL, Sisodia SS (1995a)
Distribution of an APP homolog, APLP2, in the mouse olfactory system:
a potential role for APLP2 in axogenesis. J Neurosci 15:6314–6326.
Thinakaran G, Slunt HH, Sisodia SS (1995b) Novel regulation of chon-
droitin sulfate glycosaminoglycan modification of amyloid precursor pro-
tein and its homologue, APLP2. J Biol Chem 270:16522–16525.
Thinakaran G, Slunt HH, Spitzer L, Lee MK, Sisodia SS (1995c) Tissue
distribution and developmental expression of the amyloid precursor
protein homolog, APLP1. Soc Neurosci Abstr 21:205.
Tremml P, Mu¨ller U, Lipp H-P, Wolfer DP (1997) Neurobehvioral devel-
opment, adult open-field activity and swimming navigation learning in
mice underexpressing bAPP and in mice lacking APLP1. Soc Neurosci
Abstr 23:1637.
Tremml P, Lipp HP, Mu¨ller U, Ricceri L, Wolfer DP (1998) Neurobehav-
ioral development, adult openfield exploration and swimming navigation
learning in mice with a modified beta-amyloid precursor protein gene.
Behav Brain Res 95:65–76.
von Koch CS, Zheng H, Chen H, Trumbauer M, Thinakaran G, van der
Ploeg LH, Price DL, Sisodia SS (1997) Generation of APLP2 KO mice
and early postnatal lethality in APLP2/APP double KO mice. Neurobiol
Aging 18:661–669.
Wasco W, Bupp K, Magendantz M, Gusella JF, Tanzi RE, Solomon F
(1992) Identification of a mouse brain cDNA that encodes a protein
related to the Alzheimer disease-associated amyloid beta protein precur-
sor. Proc Natl Acad Sci USA 89:10758–10762.
Wasco W, Gurubhagavatula S, Paradis MD, Romano DM, Sisodia SS,
Hyman BT, Neve RL, Tanzi RE (1993) Isolation and characterization
of APLP2 encoding a homologue of the Alzheimer’s associated amyloid
beta protein precursor. Nat Genet 5:95–100.
White AR, Zheng H, Galatis D, Maher F, Hesse L, Multhaup G,
7962 J. Neurosci., November 1, 2000, 20(21):7951–7963 Heber et al. • Mice with Combined Gene Deficiencies of APP Family Members
Beyreuther K, Masters CL, Cappai R (1998) Survival of culturedneu-
rons from amyloid precursor protein knock-out mice against Alzheimer’s
amyloid-beta toxicity and oxidative stress. J Neurosci 18:6207–6217.
White AR, Multhaup G, Maher F, Bellingham S, Camakaris J, Zheng H,
Bush AI, Beyreuther K, Masters CL, Cappai R (1999a) The Alzhei-
mer’s disease amyloid precursor protein modulates copper-induced tox-
icity and oxidative stress in primary neuronal cultures. J Neurosci
19:9170–9179.
White AR, Reyes R, Mercer JFB, Camakaris J, Zheng H, Bush AI,
Multhaup G, Beyreuther K, Masters CL, Cappai R (1999b) Copper
levels are increased in the cerebral cortex and liver of APP and APLP2
knock-out mice. Brain Res 842:439–444.
Xu X, Yang DS, Wyss-Coray T, Yan J, Gan L, Sun Y, Mucke L (1999)
Wild-type but not Alzheimer-mutant amyloid precursor protein confers
resistance against p53-mediated apoptosis. Proc Natl Acad Sci USA
96:7547–7552.
Yamazaki T, Selkoe DJ, Koo EH (1995) Trafficking of cell surface beta-
amyloid precursor protein: retrograde and transcytotic transport in cul-
tured neurons. J Cell Biol 129:431–442.
Zheng H, Jiang MH, Trumbauer ME, Sirinathsinghji DJS, Hopkins R,
Smith DW, Heavens RP, Dawson GR, Boyce S, Conner MW, Stevens
KA, Slunt HH, Sisodia SS, Chen HY, Vanderploeg LHT (1995) Beta-
amyloid precursor protein-deficient mice show reactive gliosis and de-
creased locomotor activity. Cell 81:525–531.
Heber et al. • Mice with Combined Gene Deficiencies of APP Family Members J. Neurosci., November 1, 2000, 20(21):7951–7963 7963
